Patents by Inventor Serguei Moussatov

Serguei Moussatov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF APOPTOSIS INHIBITING COMPOUNDS IN DEGENERATIVE NEUROLOGICAL DISORDERS
    Publication number: 20120039991
    Abstract: The invention provides methods and compositions for localized delivery of a vector comprising a therapeutic agent to a specific region of the brain associated with a neurodegenerative diseases that is characterized by an excess buildup of buildup of intracellular protein aggregates. In particular, the invention provides methods and compositions used to deliver an adeno-associated virus vector (AAV) comprising a nucleotide sequence encoding an inhibitor of apoptosis protein (IAP) to cells in the region.
    Type: Application
    Filed: August 17, 2011
    Publication date: February 16, 2012
    Applicant: NEUROLOGIX, INC.
    Inventors: Michael Kaplitt, Serguei Moussatov
  • Use of apotosis inhibiting compounds in degenerative neurological disorders
    Patent number: 8017385
    Abstract: The invention provides methods and compositions for localized delivery of a vector comprising a therapeutic agent to a specific region of the brain associated with a neurodegenerative diseases that is characterized by an excess buildup of buildup of intracellular protein aggregates. In particular, the invention provides methods and compositions used to deliver an adeno-associated virus vector (AAV) comprising a nucleotide sequence encoding an inhibitor of apoptosis protein (IAP) to cells in the region.
    Type: Grant
    Filed: October 21, 2005
    Date of Patent: September 13, 2011
    Assignee: Neurologix, Inc.
    Inventors: Michael Kaplitt, Serguei Moussatov
  • PINK-1 promoter
    Publication number: 20060228776
    Abstract: The invention provides methods and compositions of an upstream regulatory element (PINK-1 promoter) operably linked to an expressible gene, wherein the expression of the expressible gene is driven by the upstream regulatory element.
    Type: Application
    Filed: October 21, 2005
    Publication date: October 12, 2006
    Applicant: NEUROLOGIX, INC.
    Inventors: Michael Kaplitt, Serguei Moussatov
  • Use of apotosis inhibiting compounds in degenerative neurological disorders
    Publication number: 20060210538
    Abstract: The invention provides methods and compositions for localized delivery of a vector comprising a therapeutic agent to a specific region of the brain associated with a neurodegenerative diseases that is characterized by an excess buildup of buildup of intracellular protein aggregates. In particular, the invention provides methods and compositions used to deliver an adeno-associated virus vector (AAV) comprising a nucleotide sequence encoding an inhibitor of apoptosis protein (IAP) to cells in the region.
    Type: Application
    Filed: October 21, 2005
    Publication date: September 21, 2006
    Applicant: NEUROLOGIX, INC.
    Inventors: Michael Kaplitt, Serguei Moussatov